Browsing Brage NIH by Author "Lindman, Henrik"

Now showing items 1-2 of 2

    • Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment?: The phys-can randomized clinical trial 

      Demmelmaier, Ingrid; Brooke, Hannah L.; Henriksson, Anna; Mazzoni, Anne-Sophie; Bjørke, Ann Christin Helgesen; Igelström, Helena; Ax, Anna-Karin; Sjövall, Katarina; Hellbom, Maria; Pingel, Ronnie; Lindman, Henrik; Johansson, Silvia; Velikova, Galina; Raastad, Truls; Buffart, Laurien M.; Åsenlöf, Pernilla; Aaronson, Neil K.; Glimelius, Bengt; Nygren, Peter; Johansson, Birgitta; Börjeson, Sussanne; Berntsen, Sveinung; Nordin, Karin (Peer reviewed; Journal article, 2021)
      Exercise during cancer treatment improves cancer-related fatigue (CRF), but the importance of exercise intensity for CRF is unclear. We compared the effects of high- vs low-to-moderate-intensity exercise with or without ...

    • Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer 

      Schauer, Tim; Henriksson, Anna; Strandberg, Emelie; Lindman, Henrik; Berntsen, Sveinung; Demmelmaier, Ingrid; Raastad, Truls; Nordin, Karin; Christensen, Jesper F. (Peer reviewed; Journal article, 2022)
      Background Chemotherapy efcacy is largely dependent on treatment adherence, defned by the relative dose intensity (RDI). Identifcation of new modifable risk factors associated with low RDI might improve chemotherapy delivery. ...